| |
| Michael C.Mackey (Montreal) |
| Understanding cyclical thrombocytopenia: Amathematical modeling approach (Journal of Theoretical Biology) |
Raluca Apostu, Michael C.Mackey
 |
| Oscillations in cyclical neutropenia: new evidence based on mathematical modeling
(Journal of Theoretical Biology)
| Samuel Bernarda, Jacques Belair, Michael C.Mackey |
| Cell replication and Control
| Michael C.Mackey, caroline Haurie, Jacques Belair |
| Mathematical Models of Hematopetic Cell Replication and Control
| Michael Mackey |
| A mathematical model of hematopoiesis - I. Periodic chronic myelogenous leukemia
(Journal of Theoretical Biology)
| Caroline Colijn, Michael C.Mackey |
| A mathematical model o fhe matopoiesis: II.Cyclical neutropenia
| Caroline Colijn, Michael C.Mackey |
| Observations on the Pathophysiology and Mechanisms for Cyclic
neutropenia
| Caroline Colijn, David C. Dale, Catherine Foley, Michael C.Mackey |
| Cost-effective G-CSF therapystrategies for cyclical neutropenia:Mathematical modelling based hypotheses
| Catherine Foley, Samuel Bernard, Michael C.Mackey |
| G-CSF treatment of canine cyclical neutropenia: A comprehensive mathematical model
(ExperimentalHematology35-2007)
| Caroline Colijn, Catherine Foley, Michael C.Mackey |
| Dynamic Hematological Disease: A Review
(Journal of Mathematical Biology manuscript)
| Catherine Foley, Michael C.Mackey |
| Andrea Ciliberto (Milan) |
| Irreversible cell-cycle transitions are due to systems-level feedback
| Bela Novak, John J. Tyson, Bela Gyorffy and Attila Csikasz-Nagy |
| Hysteresis drives cell-cycle transitions in Xenopus laevis egg extracts
| Wei Sha, Jonathan Moore, Katherine Chen, Antonio D. Lassaletta ,Chung-Seon Yi, John J.Tyson, and Jill C.Sible |
| There versibility o fmitotic exit in vertebrate cells
| Tamara A.Potapova, John R.Daum, Bradley D.Pittman, Joanna R.Hudson,Tara N.Jones, David L.Satinover, P.Todd Stukenberg &Gary J. Gorbsky |
| Stephan Luckhaus (Leipzig) |
The Continuum Reaction-Diffusion Limit of a Stochastic Cellular Growth Model
(Rend. Mat. Acc. Linceis. 9, v. 15:215-223-2004)
| Stephan Luckhaus, Livio Triolo
|
| Paolo Ubezio (Milan) |
| Simulating cancer-cell kinetics after drug treatment:Application tocisplatin on ovarian carcinoma
| F.Montalenti, G.Sena, P.Cappella and P. Ubezio |
| Uraveling the complexity of cell cycle effects of anticancer drugs in cell population
| Paolo Ubezio |
| Bertrand Tavitian (CEA Saclay) |
| Segmentation of Rodent Whole-Body Dynamic PET Images: an unsupervised method based on voxel dynamics
| Renaud Maroy, Raphaël Boisgard, Claude Comtat, Member, IEEE, Vincent Frouin, Pascal Cathier, Edouard Duchesnay, Frédéric Dollé, Peter Nielsen, Régine Trébossen and Bertrand Tavitian |
| Luigi Preziosi (Turin) |
| Multiphase Models of Tumour Growth
| S. Astanin, Luigi Preziosi |
On the Closure of Mass Balance Models for Tumor Growth
(Mathematical Models and Method sin Applied SciencesVol.12, No.5-2002)
| D.Ambrosi, L. Preziosi |
| Mechanics
in Tumor Growth
| L. Raziano, L.Preziosi |
| Olivier Saut (Bordeaux) |
| Réaction - diffusion équations
and models od tumor growth
invasion
| Olivier Saut (Institut de Mathématiques de Bordeaux) |
| Benoît Perthame (INRIA Paris-Rocquencourt) |
The dynamics of adaptation: an illuminating example and a Hamilton-Jacobi approach
(Th.Pop.Biol.,67-(4)-2005)
| Odo Diekmann, Pierre-Emanuel Jabin, Séphane Mischler and Benoît Perthame |
| Sriram Krishnamachari (INRIA Paris-Rocquencourt) |
| Robustness of Molecular Networks in Normal and Cancer cell Cycles
| Sriram Krishnamachari (INRIA project-team CONTRAINTES) |
| Biological Robutness
| Hiroaki Kitano |
| Cancer as a robust system: implications for anticancer therapy
| Hiroaki Kitano |
| Robustness of Cellular Functions
(Cell,Vol.118,675–685,September17,2004)
| Jörg Stelling, Uwe Sauer, Zoltan Szallasi, Francis J.Doyle,III, and John Doyle |
| David Dingli (MN, USA)
|
| Allometric Scaling of the Active Hematopoietic Stem Cell Pool across Mammals
| David Dingli, Jorge M.Pacheco |
| On the Origin of Multiple Mutant Clones in Paroxysmal Nocturnal
Hemoglobinuria
(Stem Cells) | Arne Traulsen, Jorge M. Pacheco and David Dingli |
| Blood Acquired hematopoietic stem-cell disorders and mammalian size
| Joao V. Lopes, Jorge M. Pacheco and David Dingli |
| Allometric scaling of active stem cells across mammals
(supplement) | Joao V. Lopes, Jorge M. Pacheco and David Dingli |
| Stochastic Dynamics of Hematopoietic Tumor Stem Cells
| David Dingli, Arne Traulsen, Jorge M. Pacheco |
| Some Dynamic Aspects of Hematopoietic Stem Cells
| David Dingli & Jorge M.Pacheco |
| Ontogenic growth of the haemopoieti cstem cell pool in humans (Proc.R.Soc.B -2007)
| DavidDingli & Jorge M.Pacheco |
Multiple mutant clones in blood rarely coexist
(Physical review 77-2008)
| David Dingli, Arne Traulsen, Jorge M. Pacheco |
| Compartmental Architecture and Dynamics of Hematopoiesis
| David Dingli, Arne Traulsen, Jorge M. Pacheco |
| Stephen Randall Thomas (Evry)
|
Web-Based tools for Quantitative Renal physiology
(Cellular and Molecular BiologyTM50 -7 -2004)
| V. Dzodic, S. Hervy, D. Fritsch, H. Khalfallah, M. Thereau and S.R. Thomas |
| QxDB: a generic data base to support mathematica lmodelling in biology
| Benjamin Ribba, Philippe Tracqui, Jean-Laurent Boix, Jean-pierre Boissel, and S.R. Thomas |
| Francis Lévi (Villejuif) |
| A cell cycle automaton model fo rprobing circadian patterns of anticancer drug delivery
| Atilla Altinok ,Albert Goldbeter, Francis Lévi, |
| Cancer Chronotherapy: Principles, Applications and Perspectives
| Marie-Christine Mormont, Ph.D. Francis Lévi, M.D.,Ph.D. |
| Cross-talks between Circadian Timing System and Cell DivisionCycle Determine Cancer Biology and Therapeutics
| F. Lévi, E. Filipski, I. Iurisci, X.M. Li, and P. Innominato |
Implications of circadian clocks for the rhythmic delivery of cancer therapeutics
(Advanced Drug Delivery Reviews 59, 2007
| Francis Lévi, Christian Focan, Abdoulaye Karaboué, Virginie de la Valette, Danielle Focan-Henrard, Benoît Baron, Françoise Kreutz, Sylvie Giacchetti |
Circadian Rhythms: Mechanisms and Therapeutic Implications
(Annu.Rev.Pharmacol.Toxicol.2007)
| Ueli Schibler, Francis Lévi |
| Albert Goldbeter (Bruxelles) |
Optimizing Temporal paterns of Anticancer Drug Delivery bu Simulations of a cycle Automaton
(Biosimulation in Drug development)
| Atilla Altinok, Francis Lévi, Albert Goldbeter |
| A cell cycle automaton model fo rprobing circadian patterns of anticancer drug delivery
| Atilla Altinok, FrancisLévi, Albert Goldbeter |
Version
française 
